New FDA-Approved Pergolide Product
A new FDA-approved Pergolide product offers options in the management of clinical signs associated with pituitary pars intermedia dysfunction (PPID), also known as equine Cushing’s disease.
- Topics: AAEP Convention 2011, Cushing's Disease, Media, News & Interviews, Video
Share
ADVERTISEMENT
A new FDA-approved Pergolide product offers options in the management of clinical signs associated with pituitary pars intermedia dysfunction (PPID), also known as equine Cushing’s disease.
Share
The Horse Staff
The Horse: Your Guide To Equine Health Care is an equine publication providing the latest news and information on the health, care, welfare, and management of all equids.
More articles by this Author
Related Articles
Stay on top of the most recent Horse Health news with
